Hematology News100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'January 21, 2022TransplantAggressive LymphomasALLDLBCLCLLTranslational ResearchB Cell Lymphoma
Oncology PracticeRituximab and COVID-19 vaccines: Studies begin to answer key questionsJanuary 21, 2022COVID-19 UpdatesLymphoma & Plasma Cell DisordersCLLB Cell LymphomaDLBCL
Hematology NewsCLL and COVID-19: Outcome trends and lessons learnedDecember 8, 2021CLLCOVID-19 Updates
Hematology NewsVenetoclax heralded a new class of small-molecule blood cancer drugsNovember 15, 2021CLL
Hematology NewsBTKi resistance: ‘Achilles’ heel’ in effective treatment of B-cell malignanciesOctober 15, 2021CLLB Cell Lymphoma
Hematology NewsTransfusions, readmissions higher for patients with CLL after cardiac surgerySeptember 20, 2021CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsTargeted CLL treatments found effective in managing associated autoimmune cytopeniasJuly 15, 2021CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsGLOW: Ibrutinib+venetoclax shines in first line for CLL/SLLJune 14, 2021CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsPatients with CLL have significantly reduced response to COVID-19 vaccine May 16, 2021CLLCOVID-19 Updates
Hematology NewsPediatric cancer survivors at risk for opioid misuseMay 5, 2021ALLPatient & Survivor CareOpioid Resource CenterPediatricsCNS/Brain CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsGENUINE improvements: Ublituximab plus ibrutinib for CLLApril 21, 2021CLLLeukemia, Myelodysplasia, Transplantation
Hematology NewsCLL patients: Diagnostic difficulties, treatment confusion with COVID-19April 19, 2021CLLCOVID-19 UpdatesLeukemia, Myelodysplasia, Transplantation
